Semaglutide and Ozempic-like drugs may improve kidney disease outcomes
Semaglutide, a medication commonly sold as Ozempic or Wegovy, is typically associated with weight loss. But it can…
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more…
Experts Call for End to Routine ‘Corrected’ Calcium Reporting
An international coalition of experts in laboratory medicine, osteoporosis, and chronic kidney disease is calling for laboratories to…
Dr Hook frontman Dennis Locorriere dies aged 76
Dr Hook frontman Dennis Locorriere has died aged 76 after a “long and courageous battle” with kidney disease,…
New map reveals B cell clusters linked to faster diabetic kidney disease
A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD)…
Type 1 diabetes preserves fitness but alters oxygen use in teens
Even when fitness looks normal, hidden changes in oxygen use and microvascular function may already be emerging in…
Beyond the Dialysis Machine: Shaping the Future of Kidney and Cardiovascular Health
Newswise — For many patients, dialysis is not just a treatment—it becomes a defining part of life. Hours…
CFHR1 could be a new diagnostic marker for IgA nephropathy
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs)…
How Isabella Lenihan-Ikin saved her aunt’s life with a kidney
When Rhodes Scholar Isabella Lenihan-Ikin’s beloved aunt Brigid Lenihan needed a new kidney, there was no doubt in…
Can a simple lab test prevent bigger health problems?
We have written before about what specific blood panels reveal and how vitamin deficiencies show up in your…
Veterans: Make kidney disease screening a priority
More than 1.4 million Veterans enrolled in VA health care are living with chronic kidney disease, a key…
GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
A major real-world analysis suggests GLP-1 receptor agonists could offer heart, kidney, and weight benefits in type 1…